Literature DB >> 33386486

The activity of yeast Apn2 AP endonuclease at uracil-derived AP sites is dependent on the major carbon source.

Kasey Stokdyk1,2, Alexandra Berroyer1,3, Zacharia A Grami1,4, Nayun Kim5,6.   

Abstract

Yeast Apn2 is an AP endonuclease and DNA 3'-diesterase that belongs to the Exo III family with homology to the E. coli exonuclease III, Schizosaccharomyces pombe eth1, and human AP endonucleases APEX1 and APEX2. In the absence of Apn1, the major AP endonuclease in yeast, Apn2 can cleave the DNA backbone at an AP lesion initiating the base excision repair pathway. To study the role and relative contribution of Apn2, we took advantage of a reporter system that was previously used to delineate how uracil-derived AP sites are repaired. At this reporter, disruption of the Apn1-initiated base excision repair pathway led to a significant elevation of A:T to C:G transversions. Here we show that such highly elevated A:T to C:G transversion mutations associated with uracil residues in DNA are abolished when apn1yeast cells are grown in glucose as the primary carbon source. We also show that the disruption of Apn2, either by the complete gene deletion or by the mutation of a catalytic residue, results in a similarly reduced rate of the uracil-associated mutations. Overall, our results indicate that Apn2 activity is regulated by the glucose repression pathway in yeast.

Entities:  

Keywords:  AP endonuclease; DNA repair; Glucose repression; Uracil in DNA

Mesh:

Substances:

Year:  2021        PMID: 33386486      PMCID: PMC8035244          DOI: 10.1007/s00294-020-01141-4

Source DB:  PubMed          Journal:  Curr Genet        ISSN: 0172-8083            Impact factor:   3.886


  47 in total

Review 1.  The endonuclease IV family of apurinic/apyrimidinic endonucleases.

Authors:  James M Daley; Chadi Zakaria; Dindial Ramotar
Journal:  Mutat Res       Date:  2010-08-03       Impact factor: 2.433

Review 2.  DNA repair mechanisms and the bypass of DNA damage in Saccharomyces cerevisiae.

Authors:  Serge Boiteux; Sue Jinks-Robertson
Journal:  Genetics       Date:  2013-04       Impact factor: 4.562

3.  Discrimination between paralogs using microarray analysis: application to the Yap1p and Yap2p transcriptional networks.

Authors:  Barak A Cohen; Yitzhak Pilpel; Robi D Mitra; George M Church
Journal:  Mol Biol Cell       Date:  2002-05       Impact factor: 4.138

4.  Abasic sites linked to dUTP incorporation in DNA are a major cause of spontaneous mutations in absence of base excision repair and Rad17-Mec3-Ddc1 (9-1-1) DNA damage checkpoint clamp in Saccharomyces cerevisiae.

Authors:  Ada Collura; Patricia Auffret Van Der Kemp; Serge Boiteux
Journal:  DNA Repair (Amst)       Date:  2012-01-04

Review 5.  Deoxyuracil in DNA and disease: Genomic signal or managed situation?

Authors:  James Chon; Martha S Field; Patrick J Stover
Journal:  DNA Repair (Amst)       Date:  2019-02-27

6.  The Saccharomyces cerevisiae ETH1 gene, an inducible homolog of exonuclease III that provides resistance to DNA-damaging agents and limits spontaneous mutagenesis.

Authors:  R A Bennett
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

Review 7.  Posttranslational modification of mammalian AP endonuclease (APE1).

Authors:  Carlos S Busso; Michael W Lake; Tadahide Izumi
Journal:  Cell Mol Life Sci       Date:  2010-08-14       Impact factor: 9.261

8.  Ubiquitination of mammalian AP endonuclease (APE1) regulated by the p53-MDM2 signaling pathway.

Authors:  C S Busso; T Iwakuma; T Izumi
Journal:  Oncogene       Date:  2009-02-16       Impact factor: 9.867

9.  Re-engineering multicloning sites for function and convenience.

Authors:  Nathan C Crook; Elizabeth S Freeman; Hal S Alper
Journal:  Nucleic Acids Res       Date:  2011-05-17       Impact factor: 16.971

10.  DISULFIND: a disulfide bonding state and cysteine connectivity prediction server.

Authors:  Alessio Ceroni; Andrea Passerini; Alessandro Vullo; Paolo Frasconi
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.